Cumulative cardiovascular-kidney-metabolic burden, adverse cardiac remodeling and clinical events: A life-course analysis of MESA and CARDIA
American Journal of Preventive Cardiology · 2026-11 · 102565
DOI: 10.1016/j.ajpc.2026.102565 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-11. Verfasst von Ashkan Abdollahi und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Heart Lung and Blood Institute, National Institute on Aging, American Heart Association Inc.
Abstract (Originalsprache)
Background
Cardiovascular-kidney-metabolic (CKM) syndrome integrates adiposity, metabolic dysfunction, and kidney disease into a continuum of cardiovascular (CV) risk. The implications of cumulative CKM burden over time and across the lifespan remain less explored.
Objectives
To relate cumulative CKM burden to downstream cardiac remodeling and incident CV events.
Methods
We studied CARDIA (enrolled at 18–30 years) and MESA (45–84 years, free of clinical CV disease). Cumulative CKM-years were defined as the area under the CKM stage versus time curve from baseline to a landmark visit (Year 25 in CARDIA; Exam 5 in MESA); cumulative body mass index (BMI)-years were derived identically. Exposures were related to downstream echocardiography and incident 3-point major adverse CV events (MACE), adjusting for demographics, risk factors, and baseline exposure.
Results
Among 2968 CARDIA (age 25±4 years; 56% women) and 4294 MESA participants (age 61±9 years; 53% women), CKM stages 3–4 rose from 0.1% to 28.7% and from 49.7% to 71.1%, respectively. Greater cumulative CKM-years were associated with higher left ventricular (LV) mass index, left atrial volume index, E/e', and worse global longitudinal strain in both cohorts. Over a median 8.9 and 8.7 years, each standard deviation increment was associated with higher MACE risk (CARDIA: HR 2.35 [95% CI: 1.79–3.09]; MESA: 1.71 [1.40–2.09]), including after adjustment for landmark CKM stage. In MESA, structural remodeling was largely explained by concurrent CKM stage. Cumulative BMI-years remained associated with cardiac remodeling beyond baseline BMI in CARDIA, with a significant interaction with baseline BMI in relation to LV mass observed in both cohorts.
Conclusions
Greater cumulative CKM burden was associated with adverse cardiac remodeling and higher CV event risk across the life course. These findings support longitudinal assessment of CKM burden and cumulative adiposity rather than reliance on single time-point measures.
Förderung
- National Heart Lung and Blood Institute
- National Institute on Aging
- American Heart Association Inc
Zitieren
APA
Abdollahi, A., Sani, M. M., Spatz, E. S., Khera, R., Gidding, S. S., Ndumele, C. E., Shah, S. J., Lima, J. A., & Oikonomou, E. K. (2026). Cumulative cardiovascular-kidney-metabolic burden, adverse cardiac remodeling and clinical events: A life-course analysis of MESA and CARDIA. American Journal of Preventive Cardiology, 102565. https://doi.org/10.1016/j.ajpc.2026.102565
Vancouver
Abdollahi A, Sani MM, Spatz ES, Khera R, Gidding SS, Ndumele CE, et al. Cumulative cardiovascular-kidney-metabolic burden, adverse cardiac remodeling and clinical events: A life-course analysis of MESA and CARDIA. American Journal of Preventive Cardiology. 2026:102565. doi:10.1016/j.ajpc.2026.102565
BibTeX
@article{Abdollahi2026,
author = {Abdollahi, Ashkan and Sani, Maryam Mojarrad and Spatz, Erica S. and Khera, Rohan and Gidding, Samuel S. and Ndumele, Chiadi E. and Shah, Sanjiv J. and Lima, João A.C. and Oikonomou, Evangelos K.},
title = {Cumulative cardiovascular-kidney-metabolic burden, adverse cardiac remodeling and clinical events: A life-course analysis of MESA and CARDIA},
journal = {American Journal of Preventive Cardiology},
year = {2026},
pages = {102565},
doi = {10.1016/j.ajpc.2026.102565}
}
EUVIMED